Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer, meaning it starts in the main cells of the liver itself. Your liver is a vital organ responsible for filtering toxins, producing essential proteins, and aiding digestion. When HCC develops, it can interfere with these critical functions and, if not caught early, can spread to other parts of the body. This condition most often develops in people who have existing chronic liver disease, particularly those with cirrhosis (scarring of the liver). Common risk factors include long-term infections with hepatitis B or C viruses, heavy alcohol consumption, non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), and certain inherited metabolic disorders. These conditions damage liver cells over time, increasing the likelihood of cancerous changes. Lab tests, like the ones you may have received, play a crucial role in managing HCC. They are used for screening individuals at high risk (e.g., those with cirrhosis) to detect cancer at its earliest, most treatable stages. Additionally, blood tests can help diagnose HCC, monitor its progression, and assess how well treatments are working. Understanding these results helps your healthcare team tailor the best possible care plan for you.